Core Viewpoint - Carlsmed, Inc. has successfully completed its first cervical procedure using the aprevo® system, marking a significant milestone in the expansion of its AI-enabled personalized spine surgery solutions [1][3]. Company Overview - Carlsmed is a medical technology company focused on pioneering AI-enabled personalized spine surgery solutions, aiming to improve healthcare outcomes and reduce costs associated with spine surgery [4]. Product Details - The aprevo® devices are designed to cater to the unique anatomical and alignment needs of each patient through a proprietary AI-powered surgical planning platform and digital production system [2]. - The system allows for a level of alignment in cervical fusion surgery that is believed to be unattainable with traditional implants, representing a meaningful advancement in surgical practices [3]. Strategic Goals - The company aims to reduce the need for revision surgeries, improve patient outcomes, and enhance overall value within the healthcare system, working towards establishing a new standard of care [3]. - Carlsmed has received Breakthrough Device designation for the aprevo® cervical from the FDA and anticipates a commercial launch in the United States in 2026 [3].